RUNX1 and prostate cancer: Although the prostate gland phenotypes have not been reported, a study in which ChIP-seq analysis was performed recently demonstrated that RUNX1 is recruited to androgen receptor binding sites and that Runx1 positively regulates androgen-dependent prostate cancer growth [6].